Chinese developer Evergrande this week defaulted. We examine China's massive debt woes and other investment risks. Read More

Federal law enforcement officials recently told Congress that they want to make it easier for scientists to study cannabis (and even LSD). Read More

These are volatile and unnerving times, but robust corporate earnings projections should be sufficient medicine to keep stocks aloft. Read More

There's a contrarian Wall Street adage that's acutely applicable here: Buy them when no one wants them. Read More

Remaining logical when the herd panics is always a good idea when investing, but it’s especially important during pandemic-induced selloffs. Read More

A surge of mergers and acquisitions is transforming the marijuana industry, bringing together blue-chip financiers with pot pioneers. Read More

Despite the coronavirus and its variants, stocks continue to climb a wall of worry, as investors overcome a succession of fears and obstacles. Read More

December is an opportune time to conduct important annual financial work. One of our top experts reveals his regimen. Read More

We’re witnessing greater market volatility amid the latest COVID mutation. As 2022 looms, here are the risks and rewards for investors. Read More

The restaurant sector has taken a beating since the emergence of the Omicron variant of COVID-19, and here is how you can profit from it. Read More